References
Alings M and
Wilde A
(1999)
Brugada syndrome: clinical data and suggested pathophysiological mechanism.
Circulation
99:
666–673.
Antzelevitch C
(2001a)
The Brugada syndrome: diagnostic criteria and cellular mechanisms.
European Heart Journal
22:
356–363.
Antzelevitch C
(2001b)
The Brugada syndrome: ionic basis and arrhythmia mechanisms.
Journal of Cardiovascular Electrophysiology
12:
268–272.
Arad M,
Moskowitz IP,
Patel VV et al.
(2003)
Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff‐Parkinson‐White syndrome in glycogen storage cardiomyopathy.
Circulation
107:
2850–2856.
Arking DE,
Pfeufer A,
Post W et al.
(2006)
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization.
Nature Genetics
38:
644–651.
Barhanin J,
Lesage F,
Guillemare E et al.
(1996)
K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current.
Nature
384:
78–80.
Basson CT,
Huang T,
Lin RC et al.
(1999)
Different TBX5 interactions in heart and limb defined by Holt‐Oram syndrome mutations.
Proceedings of the National Academy of Sciences of the USA
96:
2919–2924.
Berul CI,
Maguire CT,
Aronovitz MJ et al.
(1999)
DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model.
Journal of Clinical Investigation
103:
R1–R7.
Bhuiyan ZA,
Hamdan MA,
Shamsi ET et al.
(2007)
A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14‐p22.
Journal of Cardiovascular Electrophysiology
18:
1060–1066.
Bonne G,
Di Barletta MR,
Varnous S et al.
(1999)
Mutations in the gene encoding lamin A/C cause autosomal dominant Emery‐Dreifuss muscular dystrophy.
Nature Genetics
21:
285–288.
Brugada P and
Brugada J
(1992)
Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.
Journal of American College of Cardiology
20:
1391–1396.
Bruneau BG,
Nemer G,
Schmitt JP et al.
(2001)
A murine model of Holt‐Oram syndrome defines roles of the T‐box transcription factor Tbx5 in cardiogenesis and disease.
Cell
106:
709–721.
Brugada R,
Tapscott T,
Czernuszewicz GZ et al.
(1997)
Identification of a genetic locus for familial atrial fibrillation.
New England Journal of Medicine
336:
905–911.
Calaghan SC,
Belus A and
White E
(2003)
Do stretch‐induced changes in intracellular calcium modify the electrical activity of cardiac muscle?
Progress in Biophysics and Molecular Biology
82:
81–95.
Chen L,
Marquardt ML,
Tester DJ et al.
(2007)
Mutation of an A‐kinase‐anchoring protein causes long‐QT syndrome.
Proceedings of the National Academy of Sciences of the USA
104:
20990–20995.
Durocher D,
Charron F,
Warren R,
Schwartz RJ and
Nemer M
(1997)
The cardiac transcription factors Nkx2‐5 and GATA‐4 are mutual cofactors.
EMBO Journal
16:
5687–5696.
Ebralidze A,
Wang Y,
Petkova V,
Ebralidse K and
Junghans RP
(2004)
RNA leaching of transcription factors disrupts transcription in myotonic dystrophy.
Science
303:
383–387.
Fatkin D,
MacRae C,
Sasaki T et al.
(1999)
Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction‐system disease.
New England Journal of Medicine
341:
1715–1724.
Gollob MH,
Green MS,
Tang AS et al.
(2001)
Identification of a gene responsible for familial Wolff‐Parkinson‐White syndrome.
New England Journal of Medicine
344:
1823–1831.
Gussak I,
Brugada P,
Brugada J et al.
(2000)
Idiopathic short QT interval: a new clinical syndrome?
Cardiology
94:
99–102.
Hedley PL,
Jorgensen P,
Schlamowitz S et al.
(2009)
The genetic basis of Brugada syndrome: a mutation update.
Human Mutation
30:
1256–1266.
Herfst LJ,
Rook MB and
Jongsma HJ
(2004)
Trafficking and functional expression of cardiac Na+ channels.
Journal of Molecular Cell Cardiology
36:
185–193.
Hutchison CJ,
Alvarez‐Reyes M and
Vaughan OA
(2001)
Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue‐specific disease phenotypes?
Journal of Cell Sciences
114:
9–19.
Kao WH,
Arking DE,
Post W et al.
(2009)
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community‐based populations.
Circulation
119:
940–951.
Knollmann BC and
Roden DM
(2008)
A genetic framework for improving arrhythmia therapy.
Nature
451:
929–936.
Kuo HC,
Cheng CF,
Clark RB et al.
(2001)
A defect in the Kv channel‐interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia.
Cell
107:
801–813.
Lahat H,
Pras E,
Olender T et al.
(2001)
A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine‐induced polymorphic ventricular tachycardia in Bedouin families from Israel.
American Journal of Human Genetics
69:
1378–1384.
Leenhardt A,
Lucet V,
Denjoy I et al.
(1995)
Catecholaminergic polymorphic ventricular tachycardia in children. A 7‐year follow‐up of 21 patients.
Circulation
91:
1512–1519.
Maron BJ
(2002)
Hypertrophic cardiomyopathy: a systematic review.
JAMA
287:
1308–1320.
Medeiros‐Domingo A,
Kaku T,
Tester DJ et al.
(2007)
SCN4B‐encoded sodium channel beta4 subunit in congenital long‐QT syndrome.
Circulation
116:
134–142.
Mohler PJ,
Schott JJ,
Gramolini AO et al.
(2003)
Ankyrin‐B mutation causes type 4 long‐QT cardiac arrhythmia and sudden cardiac death.
Nature
421:
634–639.
Morita H,
Wu J and
Zipes DP
(2008)
The QT syndromes: long and short.
Lancet
372:
750–763.
Muchir A,
Bonne G,
van der Kooi AJ et al.
(2000)
Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B).
Human Molecular Genetics
9:
1453–1459.
Napolitano C,
Rivolta I and
Priori SG
(2003)
Cardiac sodium channel diseases.
Clinical Chemistry and Laboratory Medicine
41:
439–444.
Nerbonne JM,
Nichols CG,
Schwarz TL and
Escande D
(2001)
Genetic manipulation of cardiac K(+) channel function in mice: what have we learned, and where do we go from here?
Circulation Research
89:
944–956.
Newton‐Cheh C,
Eijgelsheim M,
Rice KM et al.
(2009)
Common variants at ten loci influence QT interval duration in the QTGEN Study.
Nature Genetics
41:
399–406.
Plaster NM,
Tawil R,
Tristani‐Firouzi M et al.
(2001)
Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.
Cell
105:
511–519.
Pogwizd SM
(1995)
Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits.
Circulation
92:
1034–1048.
Polekhina G,
Gupta A,
Michell BJ et al.
(2003)
AMPK beta subunit targets metabolic stress sensing to glycogen.
Current Biology
13:
867–871.
Priori SG,
Napolitano C,
Gasparini M et al.
(2002)
Natural history of Brugada syndrome: insights for risk stratification and management.
Circulation
105:
1342–1347.
Priori SG,
Napolitano C,
Tiso N et al.
(2001)
Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
Circulation
103:
196–200.
Probst V,
Kyndt F,
Potet F et al.
(2003)
Haploinsufficiency in combination with aging causes SCN5A‐linked hereditary Lenegre disease.
Journal of American College of Cardiology
41:
643–652.
Schimpf R,
Bauersfeld U,
Gaita F and
Wolpert C
(2005)
Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter‐defibrillator treatment for primary prophylaxis.
Heart Rhythm
2:
416–417.
Schott JJ,
Alshinawi C,
Kyndt F et al.
(1999)
Cardiac conduction defects associate with mutations in SCN5A.
Nature Genetics
23:
20–21.
Schott JJ,
Benson DW,
Basson CT et al.
(1998)
Congenital heart disease caused by mutations in the transcription factor NKX2‐5.
Science
281:
108–111.
Schulze‐Bahr E,
Neu A,
Friederich P et al.
(2003)
Pacemaker channel dysfunction in a patient with sinus node disease.
Journal of Clinical Investigation
111:
1537–1545.
Schwartz PJ,
Priori SG,
Spazzolini C et al.
(2001)
Genotype‐phenotype correlation in the long‐QT syndrome: gene‐specific triggers for life‐threatening arrhythmias.
Circulation
103:
89–95.
Splawski I,
Shen J,
Timothy KW et al.
(2000)
Spectrum of mutations in long‐QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.
Circulation
102:
1178–1185.
Splawski I,
Timothy KW,
Sharpe LM et al.
(2004)
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.
Cell
119:
19–31.
Swynghedauw B
(1999)
Molecular mechanisms of myocardial remodeling.
Physiologcal Review
79:
215–262.
Thiene G,
Nava A,
Corrado D,
Rossi L and
Pennelli N
(1988)
Right ventricular cardiomyopathy and sudden death in young people.
New England Journal of Medicine
318:
129–133.
Towbin JA and
Bowles NE
(2002)
The failing heart.
Nature
415:
227–233.
Tsai CT,
Lai LP,
Hwang JJ,
Lin JL and
Chiang FT
(2008)
Molecular genetics of atrial fibrillation.
Journal of American College of Cardiology
52:
241–250.
Ueda K,
Nakamura K,
Hayashi T et al.
(2004)
Functional characterization of a trafficking‐defective HCN4 mutation, D553N, associated with cardiac arrhythmia.
Journal of Biological Chemistry
279:
27194–27198.
Ueda K,
Valdivia C,
Medeiros‐Domingo A et al.
(2008)
Syntrophin mutation associated with long QT syndrome through activation of the nNOS‐SCN5A macromolecular complex.
Proceedings of the National Academy of Sciences of the USA
105:
9355–9360.
Vatta M,
Ackerman MJ,
Ye B et al.
(2006)
Mutant caveolin‐3 induces persistent late sodium current and is associated with long‐QT syndrome.
Circulation
114:
2104–2112.
Vincent GM,
Timothy KW,
Leppert M and
Keating M
(1992)
The spectrum of symptoms and QT intervals in carriers of the gene for the long‐QT syndrome.
New England Journal of Medicine
327:
846–852.
Wolf CM,
Arad M,
Ahmad F et al.
(2008a)
Reversibility of PRKAG2 glycogen‐storage cardiomyopathy and electrophysiological manifestations.
Circulation
117:
144–154.
Wolf CM,
Moskowitz IP,
Arno S et al.
(2005)
Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia.
Proceedings of the National Academy of Sciences of the USA
102:
18123–18128.
Wolf CM,
Wang L,
Alcalai R et al.
(2008b)
Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis‐triggered cardiac conduction system disease.
Journal of Molecular Cell Cardiology
44:
293–303.
Wu TJ,
Ong JJ,
Hwang C et al.
(1998)
Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry.
Journal of American College of Cardiology
32:
187–196.
Further Reading
Arad M,
Maron BJ,
Gorham JM et al.
(2005)
Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
New England Journal of Medicine
352:
362–372.
Chen Q,
Kirsch GE,
Zhang D et al.
(1998)
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.
Nature
392:
293–296.
Keating MT and
Sanguinetti MC
(2001)
Molecular and cellular mechanisms of cardiac arrhythmias.
Cell
104:
569–580.
Seidman JG and
Seidman C
(2001)
The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms.
Cell
104:
557–567.
Shah M,
Akar FG and
Tomaselli GF
(2005)
Molecular basis of arrhythmias.
Circulation
112:
2517–2529.